Odyssey Health (ODYY) Share-based Compensation (2019 - 2025)
Odyssey Health's (ODYY) quarterly Share-based Compensation came in at $11781.0 in Q2 2025, down 77.12% year-on-year from $51483.0 in Q2 2024, and down 67.39% quarter-over-quarter from $36131.0 in Q1 2025.
Odyssey Health (ODYY) Share-based Compensation (2019 - 2025) Analysis & Trends
Odyssey Health's Share-based Compensation history runs 7 years deep, the most recent figure standing at $11781.0 for Q2 2025.
- On a quarterly basis, Share-based Compensation fell 77.12% year-over-year to $11781.0 in Q2 2025; TTM through Jul 2025 was $108399.0, a 91.66% decrease from a year earlier, with the FY2025 full-year figure at $108399.0, down 81.24% from the prior year.
- Share-based Compensation declined to $11781.0 in Q2 2025 per ODYY's latest filing, from $36131.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $3.7 million in Q3 2021 and bottomed at -$264830.0 in Q3 2022.
- The 5-year median for Share-based Compensation is $471018.0 (2022), against an average of $607731.4.
- Across the five-year window, Share-based Compensation sank 107.2% in 2022 and jumped 3356.4% in 2024, its largest moves.
- Year by year, Share-based Compensation stood at $533105.0 in 2021, then surged by 119.22% to $1.2 million in 2022, then slumped by 99.85% to $1750.0 in 2023, then soared by 3356.4% to $60487.0 in 2024, then sank by 80.52% to $11781.0 in 2025.
- Per Business Quant, the three latest ODYY Share-based Compensation figures stand at $11781.0 (Q2 2025), $36131.0 (Q1 2025), and $60487.0 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 11,781.00 |
| Apr 30, 2025 | 11,781.00 |
| Jan 31, 2025 | 36,131.00 |
| Jan 31, 2025 | 36,131.00 |
| Oct 31, 2024 | 60,487.00 |
| Oct 31, 2024 | 60,487.00 |
| Jul 31, 2024 | 569,055.00 |
| Jul 31, 2024 | 569,055.00 |
| Apr 30, 2024 | 51,483.00 |
| Apr 30, 2024 | 51,483.00 |
| Jan 31, 2024 | 677,391.00 |
| Jan 31, 2024 | 677,391.00 |
| Oct 31, 2023 | 1,750.00 |
| Oct 31, 2023 | 1,750.00 |
| Jul 31, 2023 | 392,811.00 |
| Jul 31, 2023 | 392,811.00 |
| Apr 30, 2023 | 598,964.00 |
| Apr 30, 2023 | 598,964.00 |
| Jan 31, 2023 | 659,846.00 |
| Jan 31, 2023 | 659,846.00 |